Preparation, physicochemical properties, in vitro evaluation and release behavior of Cephalexin (cas 15686-71-2)-loaded niosomes
-
Add time:09/01/2019 Source:sciencedirect.com
In this study, optimized cephalexin-loaded niosomal formulations based on span 60 and tween 60 were prepared as a promising drug carrier system. The niosomal formulations were characterized using a series of techniques such as scanning electron microscopy, Fourier transformed infrared spectroscopy, dynamic light scattering, and zeta potential measurement. The size and drug encapsulation efficiency are determined by the type and composition of surfactant. The developed niosomal formulations showed great storage stability up to 30 days with low change in size and drug entrapment during the storage, making them potential candidates for real applications. Moreover, the prepared niosomes showed negligible cytotoxicity for HepG2 cells, measured by MTT assay. The antibacterial properties of cephalexin-loaded niosome were investigated using S. aureus and E. coli as gram-positive and gram-negative bacteria, respectively. The results showed that the encapsulation of antibiotic drug in niosomal formulation could enhance the antibacterial efficiency of the drug, where the minimum inhibitory concentration was droped from 8 µg/mL (cephalexin) to 4 µg/mL (cephalexin-loaded niosome) and from 4 µg/mL (cephalexin) to 1 µg/mL (cephalexin-loaded niosome) against E. coli and S. aureus, respectively. The findings of our study show that the improvement of cephalexin bioavailability and prolonged drug release profile could be obtained by niosomal formulation as a favorable antibiotic drug delivery system.
We also recommend Trading Suppliers and Manufacturers of Cephalexin (cas 15686-71-2). Pls Click Website Link as below: cas 15686-71-2 suppliers
Prev:Brain energy metabolism is activated after acute and chronic administration of fenproporex (cas 15686-61-0) in young rats
Next:Determination of Cephalexin (cas 15686-71-2) residual level using ultra-high-performance liquid chromatography-tandem mass spectrometry: Residue depletion study in swine) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis and characterization of basil seed mucilage coated Fe3O4 magnetic nanoparticles as a drug carrier for the controlled delivery of Cephalexin (cas 15686-71-2)09/10/2019
- Cephalexin (cas 15686-71-2) nanoparticles: Synthesis, cytotoxicity and their synergistic antibacterial study in combination with silver nanoparticles09/09/2019
- Z-scheme 2D/3D g-C3N4@ZnO with enhanced photocatalytic activity for Cephalexin (cas 15686-71-2) oxidation under solar light09/08/2019
- Effect of Cephalexin (cas 15686-71-2) after heterogeneous Fenton-like pretreatment on the performance of anaerobic granular sludge and activated sludge09/07/2019
- Star-shaped poly(ethylene oxide)‑block‑poly(caprolactone) conjugated silver nanoparticles: A colorimetric probe for Cephalexin (cas 15686-71-2) in environmental, biological and pharmaceutical samples09/06/2019
- Data ArticleData on Cephalexin (cas 15686-71-2) removal using powdered activated carbon (PPAC) derived from pomegranate peel09/05/2019
- Nanocomposite optosensor of dual quantum dot fluorescence probes for simultaneous detection of Cephalexin (cas 15686-71-2) and ceftriaxone09/04/2019
- Adsorption of tetracycline, ofloxacin and Cephalexin (cas 15686-71-2) antibiotics on boron nitride nanosheets from aqueous solution09/03/2019
- Determination of Cephalexin (cas 15686-71-2) residual level using ultra-high-performance liquid chromatography-tandem mass spectrometry: Residue depletion study in swine09/02/2019


